Contrary to the above mentioned tumor-suppressive phenotype following MERTK inhibition in CD11b + cells, the inhibition of MERTK and AXL was reported to promote colorectal cancer (CRC) progression [76]. The gene discussed is AXL; the disease is colorectal carcinoma.